Corvus Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC CRVS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

171,173

Value ($000)

1,318

Weight

0.0%

2021 Q1 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,318	0.0%	171,173	12/31/2025
2025 Q3	11/10/2025	1,310	0.0%	177,788	9/30/2025
2025 Q2	8/12/2025	647	0.0%	161,821	6/30/2025
2025 Q1	9/15/2025	95	0.0%	29,968	3/31/2025
2024 Q4	2/6/2025	160	0.0%	29,968	12/31/2024
2024 Q3	11/12/2024	83	0.0%	15,668	9/30/2024
2024 Q2	8/12/2024	29	0.0%	15,668	6/30/2024
2024 Q1	5/9/2024	28	0.0%	15,668	3/31/2024
2023 Q4	2/6/2024	28	0.0%	15,668	12/31/2023
2023 Q3	11/8/2023	23	0.0%	15,668	9/30/2023
2023 Q2	8/10/2023	36	0.0%	15,668	6/30/2023
2021 Q4	2/11/2022	28	0.0%	11,217	12/31/2021
2021 Q3	11/16/2021	55	0.0%	11,217	9/30/2021
2021 Q1	5/17/2021	43	0.0%	13,830	3/31/2021